CT-868
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Carmot Therapeutics, Inc · Phase 1 · Completed · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CT-868 | T2D only | n/r | n/r | n/r | n/r |
| Placebo | T2D only | n/r | n/r | n/r | n/r |
| Victoza | T2D only | n/r | n/r | n/r | n/r |